Clinical and Observational Trials
-
Principal Investigator:
June Y. Hou, MD
The purpose of the study is to compare how well Rina-S works against ovarian cancer, primary peritoneal cancer, or fallopian tube cancer compared to chemotherapy drugs that are already approved and used for your type of cancer. You have an equal (50:50) chance of getting Rina-S or an approved chemotherapy agent as treatment in this study. Rina-S is not approved by the United States Food and Drug Administration (FDA) because it is still undergoing clinical trials. Rina-S is a type of drug called an antibody-drug conjugate, or "ADC". An antibody-drug conjugate (ADC) is a cancer treatment that...
-
Principal Investigator:
Xiao Xu, PhD
Columbia University researchers are looking to interview people for a study on patient decisions about whether to remove the fallopian tubes when having a hysterectomy, tubal ligation, or other sterilization surgery. If you are a woman 30-49 years of age, speak English, and have had a hysterectomy (for non-cancer reasons), tubal ligation, or another type of sterilization surgery in the past 3 years, you might be eligible to participate. If you participate, you will complete an interview with a researcher remotely by phone or online (through Zoom). The interview will ask about your experience...
-
Principal Investigator:
June Y. Hou, MD
The purpose of this clinical research study is to develop a sample collection method that is less invasive than current endometrial sampling methods (uterine sample collection) and develop a diagnostic test from these samples which is as informative in diagnosing the absence of endometrial (uterine) cancer as currently available methods.
